BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 15173268)

  • 41. Application of an assay for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in urine for the assessment of tobacco-related harm.
    Lu W; Ferguson SG; Nichols DS; Patel R; Jacobson GA
    J Pharm Biomed Anal; 2016 Nov; 131():327-332. PubMed ID: 27632782
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Randomized, Controlled Study to Assess Biomarkers of Exposure in Adult Smokers Switching to Oral Nicotine Products.
    Edmiston J; Liu J; Wang J; Sarkar M
    J Clin Pharmacol; 2022 Nov; 62(11):1445-1458. PubMed ID: 35730535
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Different profiles of carcinogen exposure in Chinese compared with US cigarette smokers.
    Benowitz NL; Gan Q; Goniewicz ML; Lu W; Xu J; Li X; Jacob P; Glantz S
    Tob Control; 2015 Dec; 24(e4):e258-63. PubMed ID: 25535294
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of an electronic nicotine delivery system with 0, 8, or 36 mg/mL liquid nicotine versus a cigarette substitute on tobacco-related toxicant exposure: a four-arm, parallel-group, randomised, controlled trial.
    Cobb CO; Foulds J; Yen MS; Veldheer S; Lopez AA; Yingst JM; Bullen C; Kang L; Eissenberg T;
    Lancet Respir Med; 2021 Aug; 9(8):840-850. PubMed ID: 33857436
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A study to estimate and correlate cigarette smoke exposure in smokers in Germany as determined by filter analysis and biomarkers of exposure.
    Shepperd CJ; Eldridge AC; Mariner DC; McEwan M; Errington G; Dixon M
    Regul Toxicol Pharmacol; 2009 Oct; 55(1):97-109. PubMed ID: 19539004
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nicotine and carcinogen exposure with smoking of progressively reduced nicotine content cigarette.
    Benowitz NL; Hall SM; Stewart S; Wilson M; Dempsey D; Jacob P
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2479-85. PubMed ID: 18006940
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Racial differences in exposure and glucuronidation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).
    Muscat JE; Djordjevic MV; Colosimo S; Stellman SD; Richie JP
    Cancer; 2005 Apr; 103(7):1420-6. PubMed ID: 15726545
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chinese 'low-tar' cigarettes do not deliver lower levels of nicotine and carcinogens.
    Gan Q; Lu W; Xu J; Li X; Goniewicz M; Benowitz NL; Glantz SA
    Tob Control; 2010 Oct; 19(5):374-9. PubMed ID: 20507920
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of differing levels of tobacco-specific nitrosamines in cigarette smoke on the levels of biomarkers in smokers.
    Ashley DL; O'Connor RJ; Bernert JT; Watson CH; Polzin GM; Jain RB; Hammond D; Hatsukami DK; Giovino GA; Cummings KM; McNeill A; Shahab L; King B; Fong GT; Zhang L; Xia Y; Yan X; McCraw JM
    Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1389-98. PubMed ID: 20501750
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Exposure to Nicotine and Selected Toxicants in Cigarette Smokers Who Switched to Electronic Cigarettes: A Longitudinal Within-Subjects Observational Study.
    Goniewicz ML; Gawron M; Smith DM; Peng M; Jacob P; Benowitz NL
    Nicotine Tob Res; 2017 Feb; 19(2):160-167. PubMed ID: 27613896
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biomarkers of Exposure Among "Dual Users" of Tobacco Cigarettes and Electronic Cigarettes in Canada.
    Czoli CD; Fong GT; Goniewicz ML; Hammond D
    Nicotine Tob Res; 2019 Aug; 21(9):1259-1266. PubMed ID: 30203076
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of Long-term Nicotine Replacement Therapy vs Standard Smoking Cessation for Smokers With Chronic Lung Disease: A Randomized Clinical Trial.
    Ellerbeck EF; Nollen N; Hutcheson TD; Phadnis M; Fitzgerald SA; Vacek J; Sharpe MR; Salzman GA; Richter KP
    JAMA Netw Open; 2018 Sep; 1(5):e181843. PubMed ID: 30646142
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of biomarkers of exposure in adult cigarette smokers using Marlboro snus.
    Sarkar M; Liu J; Koval T; Wang J; Feng S; Serafin R; Jin Y; Xie Y; Newland K; Roethig HJ
    Nicotine Tob Res; 2010 Feb; 12(2):105-16. PubMed ID: 20026503
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Self-reported Tobacco use does not correlate with carcinogen exposure in smokers with head and neck cancer.
    Khariwala SS; Carmella SG; Stepanov I; Bandyopadhyay D; Nelson HH; Yueh B; Hatsukami DK; Hecht SS
    Laryngoscope; 2015 Aug; 125(8):1844-8. PubMed ID: 25877866
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Black Light Smokers: How Nicotine Intake and Carcinogen Exposure Differ Across Various Biobehavioral Factors.
    St Helen G; Benowitz NL; Ahluwalia JS; Tyndale RF; Addo N; Gregorich SE; PĂ©rez-Stable EJ; Cox LS
    J Natl Med Assoc; 2019 Oct; 111(5):509-520. PubMed ID: 31084916
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Exposure to a tobacco-specific lung carcinogen in adolescent versus adult smokers.
    Hertsgaard LA; Hanson K; Hecht SS; Lindgren BR; Luo X; Carmella SG; Riley WT; Zylla EB; Murphy SE; Hatsukami DK
    Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3337-43. PubMed ID: 19064548
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biomonitoring of environmental tobacco smoke (ETS)-related exposure to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).
    Michael Meger Irmtrud Meger-Kossien Kirsten Riedel Gerhard Scherer
    Biomarkers; 2000; 5(1):33-45. PubMed ID: 23885904
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differences in the urinary metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in black and white smokers.
    Richie JP; Carmella SG; Muscat JE; Scott DG; Akerkar SA; Hecht SS
    Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):783-90. PubMed ID: 9332760
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tobacco-specific N-nitrosamines and Areca-derived N-nitrosamines: chemistry, biochemistry, carcinogenicity, and relevance to humans.
    Hoffmann D; Brunnemann KD; Prokopczyk B; Djordjevic MV
    J Toxicol Environ Health; 1994 Jan; 41(1):1-52. PubMed ID: 8277523
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fetal Exposure to Carcinogens With Tobacco Use in Pregnancy: Phase 1 MAW Study Findings.
    Flanagan CA; Koller KR; Wolfe AW; Thomas TK; Benowitz NL; Renner CC; Hughes C; Hatsukami DK; Bronars C; Murphy NJ; Day G; Decker PA; Patten CA
    Nicotine Tob Res; 2016 Nov; 18(11):2162-2168. PubMed ID: 27190400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.